PRECLINICAL EVALUATION OF NANOMATERIAL-BASED THERAPEUTICS FOR TRANSLATIONAL MEDICINE

Ryan Teo (1), Ethan Tan (2), Ava Lee (3)
(1) Republic Polytechnic, Singapore,
(2) National University of Singapore, Singapore,
(3) Nanyang Technological University, Singapore

Abstract

Nanomaterial-based therapeutics have shown immense promise in translational medicine, offering innovative solutions for targeted drug delivery, cancer therapy, and regenerative medicine. The unique properties of nanomaterials, including their high surface area, biocompatibility, and ability to be engineered for specific functions, make them ideal candidates for improving the precision and efficacy of medical treatments. However, the preclinical evaluation of these nanomaterials is critical to ensuring their safety, efficacy, and clinical applicability. This study aims to evaluate the preclinical performance of nanomaterial-based therapeutics in the context of translational medicine. The research focuses on assessing the pharmacokinetics, biocompatibility, and therapeutic efficacy of nanomaterials in animal models to determine their potential for clinical translation. A series of preclinical tests were conducted using animal models to assess the pharmacokinetics, biodistribution, and toxicity of various nanomaterials. Therapeutic efficacy was evaluated through specific disease models, including cancer and wound healing, using both in vitro and in vivo techniques. The study demonstrated that nanomaterial-based therapeutics exhibited promising pharmacokinetics and high therapeutic efficacy, with minimal toxicity. Nanomaterials showed targeted drug delivery and enhanced therapeutic outcomes in preclinical models, particularly in cancer therapy. Nanomaterial-based therapeutics hold significant potential for advancing translational medicine. Preclinical evaluations confirm their promise for targeted therapy, though further research on long-term safety and clinical translation is needed.

Full text article

Generated from XML file

References

Al Qudah, T. S., Shibli, R. A., Khalaf, A., Alnairat, N., Waleed, H., Abu-Dalo, D., Rabba’a, M., Afaneh, R., Al-Qatarneh, R., & Abu-Zurayk, R. (2026). Applying nanotechnology to biotechnology: Boosting production and delivery of plant-derived secondary metabolites as therapeutic drugs. Journal of Agriculture and Food Research, 26, 102763. https://doi.org/10.1016/j.jafr.2026.102763

Angolkar, M., Paramshetti, S., Patil, D., Asha Spandana, K. M., Osmani, R. A. M., Gangadharappa, H. V., Fatease, A. A., Alamri, A. H., Hani, U., & Rajput, A. (2026). Next-generation drug delivery technologies in head and neck cancer: Current therapeutic advances and future perspectives. Pathology - Research and Practice, 282, 156453. https://doi.org/10.1016/j.prp.2026.156453

Azhar, Md., Sridhar, S. B., Shareef, J., Wadhwa, T., Meenakshi, D. U., & Malviya, R. (2026). Hyalurosomes nanoformulation strategies for intra-articular and localized drug delivery: Transforming the management of osteoarthritis. Nano-Structures & Nano-Objects, 45, 101605. https://doi.org/10.1016/j.nanoso.2025.101605

Bao, Z., Xue, Y., Chen, X., Wang, Y., Wang, J., Liu, Y., & Shao, Z. (2025). Cellulose-based nanomaterials in targeted tumor chemotherapy: A comprehensive review of design, delivery, and clinical potential. Industrial Crops and Products, 234, 121461. https://doi.org/10.1016/j.indcrop.2025.121461

Bayraç, A. T. (2026). Aptamer-based strategies for glioblastoma: From SELEX to preclinical success. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(1), 189524. https://doi.org/10.1016/j.bbcan.2025.189524

Bhairam, M., Shukla, S. S., Pandey, R. K., & Gidwani, B. (2026). Emerging frontiers of responsive nanomaterials in drug delivery systems: From design to clinical translation. OpenNano, 29, 100299. https://doi.org/10.1016/j.onano.2026.100299

Bhowmik, S., Ghosh, R., & Dev, A. (2026). Advanced disease-responsive materials as intelligent drug delivery systems for rheumatoid arthritis. Journal of Drug Delivery Science and Technology, 115, 107787. https://doi.org/10.1016/j.jddst.2025.107787

Blank, L., Pander, G., Mühlberg, E., Mier, W., & Uhl, P. (2025). Exploiting the unique properties of nanobodies: Enhancing therapeutics, drug delivery, and targeted diagnostics. Drug Discovery Today, 30(12), 104524. https://doi.org/10.1016/j.drudis.2025.104524

Chennamsetty, S., Keerikkadu, M., Shetty, A., Bangera, P. D., Tippavajhala, V. K., & Rathnanand, M. (2026). Biohybrid nanocarriers for targeted drug delivery by integrating biological interfaces with synthetic platforms for site-specific therapeutics. International Journal of Pharmaceutics, 687, 126400. https://doi.org/10.1016/j.ijpharm.2025.126400

Dalbanjan, N. P., Korgaonkar, K., Eelager, M. P., Gonal, B. N., Kadapure, A. J., Arakera, S. B., & Kumar S.K., P. (2025). In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications. Nano TransMed, 4, 100091. https://doi.org/10.1016/j.ntm.2025.100091

Datta, D., Colaco, V., Nison, M., H, A. P., Bandi, S. P., Dhas, N., Pai, V. R., Halagali, P., Tippavajhala, V. K., Singh, S., & Vora, L. K. (2026). Smart microdevices for biomedical drug delivery: Endogenous stimuli as the key to safer therapeutics. RSC Advances, 16(16), 14878–14935. https://doi.org/10.1039/d5ra09767c

Dessai, A. D., Nair, A., Selvasudha, N., Garg, S., & Nayak, U. Y. (2025). Glyco-nanomaterials as a therapeutic target in drug delivery and biomedicine: A review. International Journal of Biological Macromolecules, 329, 147830. https://doi.org/10.1016/j.ijbiomac.2025.147830

Edo, G. I., Ali, A. B. M., Okolie, M. C., Orogu, J. O., Emumejaye, K., Oghroro, E. E. A., Jikah, A. N., Yousif, E., Igbuku, U. A., Owheruo, J. O., Essaghah, A. E. A., Ahmed, D. S., Makia, R. S., Umar, H., Alamiery, A. A., & Fuwape, I. A. (2026). Toxicity of nanostructures in drug delivery applications. Pharmaceutical Science Advances, 4, 100117. https://doi.org/10.1016/j.pscia.2026.100117

Emadi, R., Amiri, Z., Mortazavi Moghadam, F., Raoufi, S., Zargar Moradi, M., Asadi, S., C. Cho, W., Park, J. H., Voosough, A., Ramezani Farani, M., Hwang, S.-K., & Huh, Y. S. (2026). Self-assembling nanocomposites for smart drug delivery: Towards personalized and stimuli-responsive therapeutics. RSC Advances, 16(6), 5088–5127. https://doi.org/10.1039/d5ra07117h

Gaikwad, V., Kumbhar, S., Ansari, E., & Karale, P. (2025). Advanced anti-biofilm technologies for biomedical devices: Integrating nanomaterials, AI, and stimuli-responsive therapeutics. Intelligent Hospital, 100045. https://doi.org/10.1016/j.inhs.2025.100045

Gan, X., Li, J., Li, S., Wang, X., Wang, Q., Chen, X., Huang, Y., Nie, M., Kang, H., & Dai, H. (2025). Integrating superlubricative nanomaterials with precision drug delivery for advanced osteoarthritis therapy. Materials Today Bio, 35, 102359. https://doi.org/10.1016/j.mtbio.2025.102359

Geremamo, Y. D., Hasan, A., Razzak, S. A., & Uddin, S. (2026). Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson’s disease. International Journal of Pharmaceutics, 692, 126604. https://doi.org/10.1016/j.ijpharm.2026.126604

Gong, Z., Zhou, D., Wu, D., Han, Y., Yu, H., Shen, H., Feng, W., Hou, L., Chen, Y., & Xu, T. (2025). Challenges and material innovations in drug delivery to central nervous system tumors. Biomaterials, 319, 123180. https://doi.org/10.1016/j.biomaterials.2025.123180

Gu, L., Zhang, P., Mei, Y., Wang, Z., & He, D. (2026). Hexylaminolevulinic acid in precision medicine: A review of advances in drug delivery and combination therapeutics. Photodiagnosis and Photodynamic Therapy, 58, 105371. https://doi.org/10.1016/j.pdpdt.2026.105371

Hashmi, A. R., Zahra, F., Ravi, R. N., & Sekar, M. (2026). Engineering thiolated polyethoxylated surfactants for mucoadhesive and biointeractive lipid-based drug delivery systems: Molecular design, performance, and translational potential. Colloids and Surfaces B: Biointerfaces, 263, 115563. https://doi.org/10.1016/j.colsurfb.2026.115563

Huang, W., Hsu, J. C., Zhou, J., Kwon, G. S., Kang, L., Hua, C., & Cai, W. (2025). Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions. Matter, 8(9), 102249. https://doi.org/10.1016/j.matt.2025.102249

Javaherchi, P., Heydari, P., Salimifard, H., Zarepour, A., Khosravi, A., Iravani, S., & Zarrabi, A. (2026). Sustainable nanosystems for targeted drug delivery and their impacts on combination therapies and personalized medicine: Advancements and perspectives. Journal of Drug Delivery Science and Technology, 117, 108006. https://doi.org/10.1016/j.jddst.2026.108006

John, J. (2025). Advancements in nano-based drug delivery systems for therapeutics: A comprehensive review. RSC Pharmaceutics, 3(1), 43–59. https://doi.org/10.1039/d5pm00179j

Kanagaraj, K., Nangan, S., & Thirumalaivasan, N. (2026). Carbon dots and their role in cancer immunotherapy: Targeted drug delivery and tumor microenvironment modulation-a narrative review. Next Materials, 11, 101711. https://doi.org/10.1016/j.nxmate.2026.101711

Noury, H., Rahdar, A., Romanholo Ferreira, L. F., & Jamalpoor, Z. (2025). AI-driven innovations in smart multifunctional nanocarriers for drug and gene delivery: A mini-review. Critical Reviews in Oncology/Hematology, 210, 104701. https://doi.org/10.1016/j.critrevonc.2025.104701

Oso, T. A., Adebayo, U. O., Okesanya, O. J., Chukwu, C. N., Ayelaagbe, O. B., Obadeyi, K. B., Ogunmuyiwa-James, M. E., Yahaya, A. K., Tajudeen, K. O., Oso, O. J., Ahmed, M. M., Joy Oso, A., & Lucero-Prisno III, D. E. (2025). Nanotechnology-driven antifungal strategies: A systematic review of mechanisms, therapeutic efficacy, and translational barriers in combating drug-resistant fungal infections. Next Nanotechnology, 8, 100290. https://doi.org/10.1016/j.nxnano.2025.100290

Pandey, S., Dwivedi, A., Singh, R., Habib, N., Kashyap, D., Saini, V., Singh, A., Sharma, A., & Jha, H. C. (2026). Frontiers in glioblastoma therapy: Novel therapeutics, molecular pathways, and future clinical perspectives. Human Gene, 47, 201507. https://doi.org/10.1016/j.humgen.2025.201507

Pourbala, H., Peyvand, F., Izadi, S., Ashtiani, S. J., Rabbanian, D., Pouyanfar, N., Banan, K., Shahbazi, M.-A., Faizi, M., & Ghorbani-Bidkorpeh, F. (2026). Exploring the applications of molecularly imprinted polymers in drug delivery to the nervous system. Journal of Drug Delivery Science and Technology, 115, 107718. https://doi.org/10.1016/j.jddst.2025.107718

Sadiq, H., Rahman, M. U., Akram, H., Rehman, I. U., Ali, R., & Khan, R. (2025). Organelle-targeted nanostructured lipid carriers: Strategic design, analytical validation, and translational insights for precision intracellular drug delivery. Journal of Drug Delivery Science and Technology, 114, 107590. https://doi.org/10.1016/j.jddst.2025.107590

Sahoo, S., Behera, A., Acharya, B., & Patra, D. (2026). Recent advances in eco-friendly bionanocomposites for drug delivery of natural bioactive compounds: A sustainable approach. Nano Trends, 13, 100188. https://doi.org/10.1016/j.nwnano.2026.100188

Shahror, R. A., & Fouda, A. Y. (2025). Recent advances and future challenges in nanosystems for ocular drug delivery. The Journal of Pharmacology and Experimental Therapeutics, 392(12), 103738. https://doi.org/10.1016/j.jpet.2025.103738

Singh, L., Jain, H., Sharma, P., Singh, M., & Ezebuiro, V. (2026). Functionalized hydroxyapatite nanocomposites for localized drug delivery in bone cancer. Hybrid Advances, 12, 100609. https://doi.org/10.1016/j.hybadv.2026.100609

Xu, W., Deng, Q., Chen, L., Zhou, X., Dong, Y., Ren, C., Zeng, X., & Cao, D. (2026). Rational design of nanotherapy for ulcerative colitis: New strategies, mechanistic approaches, and translational challenges. Nanomedicine: Nanotechnology, Biology and Medicine, 71, 102894. https://doi.org/10.1016/j.nano.2025.102894

Yang, W., Ran, C., Lian, X., Wang, Z., Du, Z., Bing, T., Zhang, Y., & Tan, W. (2025). Aptamer-based targeted drug delivery and disease therapy in preclinical and clinical applications. Advanced Drug Delivery Reviews, 226, 115680. https://doi.org/10.1016/j.addr.2025.115680

Zeeshan, M., Hu, J., Mao, C.-X., Danish, A., Xiong, Y., Irshad, M. S., Dao, V.-D., & Liu, Z. (2025). Nanomaterial-enabled drug delivery systems for circadian medicine: Bridging direct rhythm modulation and chronotherapy. RSC Advances, 15(38), 31981–32008. https://doi.org/10.1039/d5ra04137f

Authors

Ryan Teo
ryanteo@gmail.com (Primary Contact)
Ethan Tan
Ava Lee
Teo, R., Tan, E., & Lee, A. . (2026). PRECLINICAL EVALUATION OF NANOMATERIAL-BASED THERAPEUTICS FOR TRANSLATIONAL MEDICINE. Journal of Biomedical and Techno Nanomaterials, 3(1), 62–73. https://doi.org/10.70177/jbtn.v3i1.3561

Article Details